indazoles has been researched along with Rhinitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beerahee, M; Cahn, A; Graves, R; Hall, D; Hodgson, S; Hughes, SC; Robertson, J; Solari, R; van Marle, S; Watson, J; Wilson, R; Young, G | 1 |
1 trial(s) available for indazoles and Rhinitis
Article | Year |
---|---|
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study.
Topics: Abdominal Pain; Administration, Oral; Adult; Aged; Area Under Curve; Biological Availability; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Headache; Humans; Indazoles; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Receptors, CCR4; Rhinitis; Sulfonamides; Young Adult | 2013 |